ACTIVE

Pharma Boulevard

Financial year 2024 · closed on 31/12/2024
Net result
187,8 k €
+148.2% YoY
Gross margin
912,6 k €
+51.2% YoY
Equity
385,6 k €
+94.9% YoY
Workforce
10,8 ETP
+31.7% YoY

What does Pharma Boulevard do?

Pharma Boulevard is a Private limited company incorporated in 2021. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Lier. It employs on average 10,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0761.844.730
Incorporation
20/01/2021
Legal form
Private limited company
Registered office
Kelderveld 37 box 2
2500 Lier · FlandreSee on map
Contributed capital
104 378,48 €
Latest accounts
31/12/2024
Average workforce
10,8 ETP
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 4 financial years

2024202320222021
Income statement
Gross margin912,6 k €603,5 k €441,8 k €128,5 k €
EBITDA364,7 k €187,5 k €131,1 k €-92 k €
Operating result281,4 k €116,3 k €59 k €-168,6 k €
Net result187,8 k €75,7 k €29,2 k €-189,1 k €
Balance sheet
Equity385,6 k €197,8 k €122,1 k €92,9 k €
Total assets1,9 M €1,8 M €1,8 M €1,5 M €
Cash116,2 k €82,9 k €3,9 k €5,4 k €
Debts1,5 M €1,6 M €1,6 M €1,4 M €
Other
Workforce10,8 ETP8,2 ETP6,6 ETP6,2 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 1 ended

Active mandates

JOKA

Director · 0474.263.880

Active
VIOS

Director · 0630.931.550

Active

Ended mandates

JOKA

Director · 0474.263.880

Ended
At this address

Other companies at this address

CompanyCBE no.
0735.391.741
0846.374.092
J & GActive
0881.672.392
LASETOActive
0808.043.652
Nature AvenueActive
0773.994.276
OTCSOLUTIONSActive
0896.972.955
PETSOLUTIONSActive
0826.398.428
Annual accounts

Full financial information

2024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202220/01/2021
Closing of the financial year31/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months
Filing date30/09/202530/09/202413/10/202331/10/2022
General meeting02/06/202503/06/202401/06/202301/06/2022
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

4 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202402/06/202530/09/2025DutchPDF
Abridged model31/12/202303/06/202430/09/2024DutchPDF
Abridged model31/12/202201/06/202313/10/2023DutchPDF
Abridged model31/12/202101/06/202231/10/2022DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 1 ended

Active mandates

JOKA

Director · 0474.263.880

Active
VIOS

Director · 0630.931.550

Active

Ended mandates

JOKA

Director · 0474.263.880

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Restructuring07/05/2021
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring23/02/2021
    KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Other22/01/2021
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024187,8 k €
  2. 2023
    Annual accounts 202375,7 k €
  3. 2022
    Annual accounts 202229,2 k €
  4. 2021
    Annual accounts 2021-189,1 k €
  5. 20/01/2021
    IncorporationPrivate limited company